AKT1 and Cognitive impairment: In a rat model of combined amyloid-beta and isoflurane-induced cognitive impairment, ketamine (2.5, 5, or 10 mg/kg) rescued spatial memory deficits on the Morris Water Maze paradigm and promoted BDNF production through upregulation of the PI3K/AKT/GSK-3β pathway.